![](../images/P020140912560618692683.jpg)
Chinese Scientists Try to Find New Therapy for Mediterranean Anemia
Dec 20, 2011 Email"> PrintText Size
China launched a research program on the treatment of beta thalassemia, a predominant type of Mediterranean anemia, in Guangzhou, the capital city of south China's Guangdong province, on Saturday.
The program will focus on the study of induced pluripotent stem cells (iPSCs) in the treatment of monogenic diseases, according to the program's chief scientist Dr. Pan Guangjin.
Scientists from several Chinese medical institutions and universities, including Guangzhou Institute of Biomedicine and Health under the Chinese Academy of Sciences (CAS), CAS Institute of Zoology, Nanfang Hospital of Southern Medical University, Hainan Medical University and Shandong University, will join the five-year program.
Mediterranean anemia, also called thalassemia, is an inherited blood disorder characterized by less hemoglobin and fewer red blood cells. Several types of thalassemia exist, including alpha thalassemia, beta- thalassemia and alpha thalassemia.
In China, the disease is most frequently seen in Sichuan, Yunnan, Guizhou, Fujian and Guangdong provinces.
Medical therapies for Mediterranean anemia include frequent blood transfusions, iron chelation and stem cell transplant.
(Source: Xinhua)
The program will focus on the study of induced pluripotent stem cells (iPSCs) in the treatment of monogenic diseases, according to the program's chief scientist Dr. Pan Guangjin.
Scientists from several Chinese medical institutions and universities, including Guangzhou Institute of Biomedicine and Health under the Chinese Academy of Sciences (CAS), CAS Institute of Zoology, Nanfang Hospital of Southern Medical University, Hainan Medical University and Shandong University, will join the five-year program.
Mediterranean anemia, also called thalassemia, is an inherited blood disorder characterized by less hemoglobin and fewer red blood cells. Several types of thalassemia exist, including alpha thalassemia, beta- thalassemia and alpha thalassemia.
In China, the disease is most frequently seen in Sichuan, Yunnan, Guizhou, Fujian and Guangdong provinces.
Medical therapies for Mediterranean anemia include frequent blood transfusions, iron chelation and stem cell transplant.
(Source: Xinhua)
CAS Institutes
There are 124 Institutions directly under the CAS by the end of 2012, with 104 research institutes, five universities & supporting organizations, 12 management organizations that consist of the headquarters and branches, and three other units. Moreover, there are 25 legal entities affiliated and 22 CAS invested holding enterprisesThere are 124 I...>> more
Contact Us
![en_about_05.jpg](../../../au/cu/201409/W020140928657613244986.jpg)
Chinese Academy of Sciences
Add: 52 Sanlihe Rd., Xicheng District, Beijing, China
Postcode: 100864
Tel: 86-10-68597592 (day) 86-10-68597289 (night)
Fax: 86-10-68511095 (day) 86-10-68512458 (night)
E-mail: cas_en@cas.cn